Participation in cancer clinical trials: Race-, sex-, and age-based disparities

JAMA

Volumn 291, Issue 22, 2004, Pages 2720-2726

  Murthy, Vivek H ^a   Krumholz, Harlan M ^a   Gross, Cary P ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; AGING; AMERICAN INDIAN; ARTICLE; BREAST CANCER; CANCER; CANCER INCIDENCE; CANCER RESEARCH; CAUCASIAN; CLINICAL TRIAL; COLORECTAL CANCER; ETHNIC GROUP; FEMALE; HISPANIC; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RACE DIFFERENCE; RISK ASSESSMENT; AGE DISTRIBUTION; BIOMEDICAL AND BEHAVIORAL RESEARCH; CROSS-SECTIONAL STUDY; EMPIRICAL APPROACH; HEALTH CARE DELIVERY; HEALTH CARE ORGANIZATION; MIDDLE AGED; MINORITY GROUP; NEOPLASM; SEX RATIO; STATISTICAL MODEL; STATISTICS; UNITED STATES; UTILIZATION REVIEW;

BIOMEDICAL AND BEHAVIORAL RESEARCH; EMPIRICAL APPROACH;

ADULT; AGE DISTRIBUTION; AGED; CLINICAL TRIALS; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MINORITY GROUPS; NATIONAL INSTITUTES OF HEALTH (U.S.); NEOPLASMS; SEX DISTRIBUTION; UNITED STATES;

EID: 2642573558     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.291.22.2720     Document Type: Article

References (46)

1. NIH Revitalization Act Subtitle B: §131-133; 1993.
2. National Cancer Institute. Are health-related exclusions keeping too many elderly patients out of cancer trials? Available at: http://www.cancer.gov/clinicaltrials/developments/ health-exclusions-a-barrier0403. Accessed July 9, 2003.
3. Stallings FL, Ford ME, Simpson NK, et al. Black participation in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials. 2000;21(6 suppl):379S-389S.
4. Financial Management Branch, National Cancer Insitute. Available at: http://www3.cancer.gov/admin/fmb/index.html. Accessed July 8, 2003.
5. NIH Clinical Trials: Various Factors Affect Patient Participation, Washington, DC: US General Accounting Office; September 1999. Document GAO/HEHS-99-182.
6. Tejeda H, Green S, Trimble E, et al. Representations of African-Americans, Hispanics, and whites in National Cancer Institute Cancer Center treatment trials. J Natl Cancer Inst. 1996;88:812-816.
7. Hutchins L, Unger J, Crowley J, et al. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med. 1999;341:2061-2067.
8. Harris DJ, Douglas PS. Enrollment of women in cardiovascular clinical trials funded by the National Heart, Lung, and Blood Institute. N Engl J Med. 2000;343:475-480.
9. Ramasubbu K, Gurm H, Litaker D. Gender bias in clinical trials: do double standards still apply? J Womens Health Gend Based Med. 2001;10:757-764.
10. Chang SM, Barker FG 2nd, Schmidt MH, et al. Clinical trial participation among patients enrolled in the Glioma Outcomes Project. Cancer. 2002;94:2681-2687.
11. Lewis JH, Kilgore ML, Goldman DP, et al. Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol. 2003;21:1383-1389.
12. Unson CG, Dunbar N, Curry L, et al. The effects of knowledge, attitudes, and significant others on decisions to enroll in a clinical trial on osteoporosis: implications for recruitment of older African-American women. J Natl Med Assoc. 2001;93:392-401.
13. Zhu K, Hunter S, Bernard LJ, Payne-Wilks K, Roland CL, Levine RS. Recruiting elderly African-American women in cancer prevention and control studies. J Natl Med Assoc. 2000;92:169-175.
14. Ford ME, Havstad SL, Tilley BC. Recruiting older African American men to a cancer screening trial (the AAMEN Project). Gerontologist. 2003;43:27-35.
15. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence-SEER 11 Registry Public Use, November 2001 Sub (1992-1999), National Cancer Institute. Available at: http://www.seer.cancer.gov/publicdata/. Accessibility verified May 11, 2004.
16. NCI PDQ Clinical Trials Search. Available at: http://www.cancer.gov/search/clinical_trials/search_clinicaltrialsadvanced.aspx. Accessed May 10, 2004.
17. Ingram D, Parker J, Schenker N, et al. United States Census 2000 Population With Bridged Race Categories. Washington, DC: National Center for Health Statistics; September 2003. Sedes 2, No. 135.
18. Bridged-race intercensal population estimates for July 1, 1990-July 1, 1999, by county, single-year of age (0, 1, ..., 85+0), Hispanic origin, and sex. April 30, 2004. Available at: http://www.cdc.gov/nchs /about/major/dvs/popbridge/popbridge.htm. Accessibility verified May 11, 2004.
19. Office of Management and Budget. Revisions to the standards for the classification of federal data on race and ethnicity. Federal Register notice, October 30, 1997. Available at: http://www.whitehouse.gov/omb/fedreg/ombdir15.html. Accessed January 5, 2004.
20. Cancer Facts and Figures-1999. Atlanta, Ga: American Cancer Society; 1999.
21. Sateren WB, Trimble EL, Abrams J, et al. How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. J Clin Oncol. 2002;20:2109-2117.
22. Stata Reference Manual. Release 8 (Volume 4). College Station, Tex: StataCorp; 2004.
23. Trimble E, Carter C, Cain D, Freidlin B, Ungerleider R, Friedman M. Representation of older patients in cancer treatment trials. Cancer. 1994;74:2208-2214.
24. Swanson GM, Ward AJ. Recruiting minorities into clinical trials: toward a participant-friendly system. J Natl Cancer Inst. 1995;87:1747-1759.
25. Robinson SB, Ashley M, Haynes MA. Attitude of African-Americans regarding prostate cancer clinical trials. J Community Health. 1996;21:77-87.
26. Harris Y, Gorelick PB, Samuels P, Bempong I. Why African Americans may not be participating in clinical trials. J Natl Med Assoc. 1996;88:630-634.
27. Corbie-Smith G, Thomas S, Williams M, Moody-Ayers S. Attitudes and beliefs of African Americans toward participation in medical research. J Gen Intern Med. 1999;14:537-546.
28. Mouton CP, Harris S, Rovi S, Solorzano P, Johnson MS. Barriers to black women's participation in cancer clinical trials. J Natl Med Assoc. 1997;89:721-727.
29. Shavers VL, Lynch CF, Burmeister LF. Racial differences in factors that influence the willingness to participate in medical research studies. Ann Epidemiol. 2002;12:248-256.
30. Shavers-Hornaday V, Lynch C, Burmeister L, Torner J. Why are African-Americans under-represented in medical research studies? impediments to participation. Ethn Health. 1997;2:31-45.
31. Brown D, Fouad M, Basen-Engquist K, Tortolero-Luna G. Recruitment and retention of minority women in cancer screening, prevention, and treatment trials. Ann Epidemiol. 2000;10:S13-S21.
32. Williams MV, Parker RM, Baker DW, et al. Inadequate functional health literacy among patients at two public hospitals. JAMA. 1995;274:1677-1682.
33. Paskett E, DeGraffinreid C, Tatum C, Margiti S. The recruitment of African-Americans to cancer prevention and control studies. Prev Med. 1996;25:547-553.
34. Gross C, Steiner C, Bass E, Powe N. Relation between prepublication release of clinical trial results and the practice of carotid endarterectomy. JAMA. 2000;284:2886-2893.
35. Crivellari D, Bonetti M, Castiglione M. Adjuvant treatment of elderly patients (PTS) with node-positive breast cancer: CMF tolerability in International Breast Cancer Study Group (IBCSG) Trial VII. Abstract 394. Available at: http://www.asco.org/ac/1,1003,_12-002643-00_18-0031-00_19-0012757,00.asp. Accessibility verified May 11, 2004.
36. Fowler J, Bigler S. A prospective study of the serum prostate specific antigen concentrations and Gleason histologic scores of black and white men with prostate carcinoma. Cancer. 1999;86:836-841.
37. Lyman G, Kuderer N, Lyman S, Cox C, Reintgen D, Baekey P. Importance of race on breast cancer survival. Ann Surg Oncol. 1997;4:80-87.
38. Farkas A, Marcella S, Rhoads G. Ethnic and racial differences in prostate cancer incidence and mortality. Ethn Dis. 2000;10:69-75.
39. Shiao Y, Chen V, Scheer W, et al. Racial disparity in the association of p53 gene alterations with breast cancer survival. Cancer Res. 1995;55:1485-1490.
40. Dignam J, Ye Y, Colangelo L. Prognosis after rectal cancer in blacks and whites participating in adjuvant therapy randomized trials. J Clin Oncol. 2003;21:413-420.
41. Rathore SS, Krumholz HM. Race, ethnic group, and clinical research. BMJ. 2003;327:763-764.
42. Meinert CL, Gilpin AK. Enrollment of women in cardiovascular clinical trials. N Engl J Med. 2000;343:1972-1973.
43. Bach PB, Guadagnoli E, Schrag D, et al. Patient demographic and socioeconomic characteristics in the SEER-Medicare database applications and limitations. Med Care. 2002;40(8 suppl):IV-19-25.
44. Frelick RW. The Community Clinical Oncology Program (CCOP) story: review of community oncologists' experiences with clinical research trials in cancer with an emphasis on the CCOP of the National Cancer Institute between 1982 and 1987. J Clin Oncol. 1994;12:1718-1723.
45. National Institute on Aging and the National Cancer Institute. Exploring the role of cancer centers in integrating aging and cancer research: workshop report. June 2001. Available at: http://www.nia.nih.gov/health/nianci/patterns.asp. Accessed July 8, 2003.
46. Cancer trial barriers falling for people over 65. Available at: http://www.cancer.gov/clinicaltrials /development/barriers-falling0101. Accessed May 10, 2004.